NSHS Stock Financial Analysis - NanoSphere Health Sciences Inc. (CNSX) Stock

Overview

NanoSphere Health Sciences Inc., based in Canada, operates within the biotechnology industry, primarily focusing on the development of innovative delivery systems for bioactive compounds. This company is renowned for its patented NanoSphere Delivery System™, a technology designed to enhance the bioavailability, efficacy, and speed of absorption of a wide array of substances. NanoSphere's flagship project revolves around the application of this technology in the cannabis sector, where it pioneers advanced solutions for both medical and recreational products. The company's endeavors extend to improving delivery methods for nutrients, pharmaceuticals, and over-the-counter medications, aiming to transform substance delivery by addressing the limitations of traditional formulations, thereby providing controlled, immediate, and sustained release options.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The operating income for NanoSphere Health Sciences Inc. as of June 30, 2025 is -0.16 MM.
The net income for NanoSphere Health Sciences Inc. as of June 30, 2025 is 0.25 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30		-0.16	0.25
2025-03-31		-0.18	0.21
2024-12-31		-0.17	0.26
2024-09-30		-0.18	-0.20
2024-06-30		-0.19	-0.20
2024-03-31		-0.20	-0.22
2023-12-31		-0.22	-0.23
2023-09-30		-0.27	-0.27
2023-06-30		-0.24	-0.26
2023-03-31		-0.25	-0.27
2022-12-31		-0.26	-0.28
2022-09-30		-0.24	-0.00
2022-06-30		-0.30	-0.32
2022-03-31		-0.36	-0.36
2021-12-31		-0.36	-0.36
2021-09-30		-0.42	-0.72
2021-06-30		-0.41	-0.44
2021-03-31		-0.38	-0.42
2020-12-31		-0.54	-0.59
2020-09-30	-0.05	-0.75	-1.75
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31
2024-09-30	-0.02	-0.02
2024-06-30	-0.02	-0.02
2024-03-31	-0.02	-0.02
2023-12-31	-0.02
2023-09-30	-0.03	-0.03
2023-06-30	-0.03	-0.03
2023-03-31	-0.03	-0.03
2022-12-31	-0.03
2022-09-30	-0.00	-0.00
2022-06-30	-0.03	-0.03
2022-03-31	-0.04	-0.04
2021-12-31	-0.05
2021-09-30	-0.13	-0.13
2021-06-30	-0.08	-0.08
2021-03-31	-0.08	-0.08
2020-12-31	-0.11
2020-09-30	-0.32	-0.32
2020-06-30	-0.47	-0.47
2020-03-31	-0.55	-0.55

Cash Flow: Operations, Investing, Financing

The cash from operating activities for NanoSphere Health Sciences Inc. as of June 30, 2025 is 0.01 MM.
The cash from financing activities for NanoSphere Health Sciences Inc. as of June 30, 2025 is 0.05 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	0.01		0.05
2025-03-31	0.01		0.03
2024-12-31	-0.04		0.03
2024-09-30	-0.03		0.03
2024-06-30	-0.01
2024-03-31	-0.02
2023-12-31	-0.05
2023-09-30	-0.03
2023-06-30	-0.04
2023-03-31	-0.08
2022-12-31	-0.07
2022-09-30	-0.10		0.00
2022-06-30	-0.10		0.18
2022-03-31	-0.06		0.18
2021-12-31	-0.06		0.18
2021-09-30	-0.05		0.20
2021-06-30	-0.01		0.03
2021-03-31	-0.01		0.01
2020-12-31	-0.05		0.03
2020-09-30	-0.15	0.00	0.01
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for NanoSphere Health Sciences Inc. as of June 30, 2025 is 6.29.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	6.29
2025-03-31	-11.11
2024-12-31	-11.07
2024-09-30	-10.45
2024-06-30	-5.51
2024-03-31	-4.44
2023-12-31	-4.11
2023-09-30	-2.78
2023-06-30	-2.84
2023-03-31	-0.01
2022-12-31	-0.01
2022-09-30	-2.09
2022-06-30	-50.17
2022-03-31	-23.50
2021-12-31	-13.10
2021-09-30	-5.48
2021-06-30	-2.67
2021-03-31	-1.71
2020-12-31	-1.77
2020-09-30	-1.21	-4.15
2020-06-30	-1.47	-2.39
2020-03-31	-1.39	-1.82

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31	1.00	8.25	7.49
2020-12-31	1.00	11.54	10.61
2020-09-30	1.00	34.25	14.63
2020-06-30	1.00	49.99	27.87
2020-03-31	1.00	63.26	36.10